Peer-reviewedCC BYFrontiers in endocrinology
Long-term GLP-1 receptor agonist therapy in obesity: expert panel recommendations for good clinical practice
15 affiliations
- 1Department of Internal Medicine, Casa di Cura Candela , ,
- 2Department of Endocrinology, Diabetes and Metabolism, Santa Croce & Carle Hospital , ,
- 3Unit of Endocrinology and Metabolism, Regina Apostolorum Hospital , , ,
- 4SC Diabetologia, ASST Grande Ospedale Metropolitano Niguarda , ,
- 5Unità Operativa Complessa (UOC) Malattie Endocrine, del Ricambio e della Nutrizione, AULSS 2 Marca Trevigiana , ,
- 6Endocrinology Unit, Diseases of Metabolism and Clinical Nutrition Unit, University Hospital S.M. Misericordia , ,
- 7Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, Interdisciplinary Department of Medicine, University of Bari “Aldo Moro” , ,
- 8Division of Endocrinology, Diabetology and Clinical Nutrition, Sant’Anna Hospital - ASST Lariana , ,
- 9Endocrinology and Metabolism Unit, Azienda Sanitaria Locale (ASL) CITTA‘ di Torino , ,
- 10Medical and Diabetological Center Centro Medico Specialistico Orio (CMSO) , ,
- 11Azienda Sanitaria Territoriale (AST) Fermo, Unit of Diabetology , ,
- 12Endocrinology and Metabolism, Regina Apostolorum Hospital. , ,
- 13Ministry of Interior - Department of Firefighters, Public Rescue and Civil Defense , ,
- 14Internal Medicine, Center for the Study and the Integrated Treatment of Obesity, Department of Medicine, University of Padova , ,
- 15Endocrinology Section, Department of Clinical and Experimental Medicine, University of Catania , ,
Related
- GLP-1 Receptor Agonist Therapy in Patients with Cancer: A Review of Clinical Outcomes
- De-escalating Therapy in Obstructive Sleep Apnoea After Glucagon-Like Peptide-1 Receptor Agonist-Induced Weight Loss: A Narrative Review
- Initiation of Glucagon-Like Peptide-1 Receptor Agonist Therapy and Lifestyle Modifications for Morbid Obesity in a Patient With Paroxysmal Atrial Fibrillation, Severe Osteoarthritis, and Obstructive Sleep Apnea: A Case Report
- Baseline depressive-symptom severity and divergent psychological trajectories during GIP and/or GLP-1 receptor agonist therapy: a prospective ecological momentary assessment study
- Syndrome-oriented CNS infectious complications after haematopoietic stem-cell transplantation and CAR T-cell therapy, part 2—focal brain infections and meningitis of bacterial, fungal, and parasitic origin: recommendations from the EBMT Practice and Harmonization Committee
BibTeX
@article{brancato2026longterm,
title = {{Long-term GLP-1 receptor agonist therapy in obesity: expert panel recommendations for good clinical practice}},
author = {Davide Brancato and Giorgio Borretta and Marco Chianelli and Olga Disoteo and Marco Grasso and Franco Grimaldi and Edoardo Guastamacchia and Fabrizio Muratori and Salvatore Oleandri and Marcello Orio and Paola Pantanetti and Enrico Papini and Agnese Persichetti and Roberto Vettor and Federica Vinciguerra},
journal = {Frontiers in endocrinology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13654747},
note = {CC BY},
}
RIS
TY - JOUR
TI - Long-term GLP-1 receptor agonist therapy in obesity: expert panel recommendations for good clinical practice
AU - Davide Brancato
AU - Giorgio Borretta
AU - Marco Chianelli
AU - Olga Disoteo
AU - Marco Grasso
AU - Franco Grimaldi
AU - Edoardo Guastamacchia
AU - Fabrizio Muratori
AU - Salvatore Oleandri
AU - Marcello Orio
AU - Paola Pantanetti
AU - Enrico Papini
AU - Agnese Persichetti
AU - Roberto Vettor
AU - Federica Vinciguerra
PY - 2026
DA - 2026/10/16
JO - Frontiers in endocrinology
UR - https://europepmc.org/article/PMC/PMC13654747
SN - 1664-2392
ER -